Cover Image
Market Research Report

Global Annuloplasty Rings Market 2020-2024

Published by TechNavio (Infiniti Research Ltd.) Product code 945158
Published Content info 120 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Annuloplasty Rings Market 2020-2024
Published: June 24, 2020 Content info: 120 Pages
Description

Technavio has been monitoring the annuloplasty rings market and it is poised to grow by $ 28.65 mn during 2020-2024 progressing at a CAGR of 3% during the forecast period. Our reports on annuloplasty rings market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of heart valve diseases and technological advances. In addition, increasing prevalence of heart valve diseases is anticipated to boost the growth of the market as well.

The annuloplasty rings market analysis include application segment and geographic landscapes

Technavio's ‘ annuloplasty rings market ’ is segmented as below:

By Application:

  • Mitral valve repair
  • Tricuspid valve repair

By Geographic Landscape:

  • North America
  • Europe
  • APAC
  • ROW

This study identifies increasing preference of mitral valve repair over mitral valve replacement as one of the prime reasons driving the annuloplasty rings market growth during the next few years.

"Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our annuloplasty rings market covers the following areas:

  • Annuloplasty rings market sizing
  • Annuloplasty rings market forecast
  • Annuloplasty rings market industry analysis"

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading annuloplasty rings market vendors that include Abbott Laboratories, BioStable Science & Engineering Inc., Boston Scientific Corp., CORONEO Inc., Edwards Lifesciences Corp., Genesee BioMedical Inc., Kephalios, LivaNova Plc, Medtronic Plc, and Valcare Medical. Also, the annuloplasty rings market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents
Product Code: IRTNTR44060

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Application

  • Market segments
  • Comparison by Application
  • Mitral valve repair - Market size and forecast 2019-2024
  • Tricuspid valve repair - Market size and forecast 2019-2024
  • Market opportunity by Application

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume drivers - Demand led growth
  • Volume drivers - External factors
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • BioStable Science & Engineering Inc.
  • Boston Scientific Corp.
  • CORONEO Inc.
  • Edwards Lifesciences Corp.
  • Genesee BioMedical Inc.
  • Kephalios
  • LivaNova Plc
  • Medtronic Plc
  • Valcare Medical

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: Application - Market share 2019-2024 (%)
  • 22: Comparison by Application
  • 23: Mitral valve repair - Market size and forecast 2019-2024 ($ million)
  • 24: Mitral valve repair - Year-over-year growth 2019-2024 (%)
  • 25: Tricuspid valve repair - Market size and forecast 2019-2024 ($ million)
  • 26: Tricuspid valve repair - Year-over-year growth 2019-2024 (%)
  • 27: Market opportunity by Application
  • 28: Customer landscape
  • 29: Market share by geography 2019-2024 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2019-2024 ($ million)
  • 32: North America - Year-over-year growth 2019-2024 (%)
  • 33: Europe - Market size and forecast 2019-2024 ($ million)
  • 34: Europe - Year-over-year growth 2019-2024 (%)
  • 35: APAC - Market size and forecast 2019-2024 ($ million)
  • 36: APAC - Year-over-year growth 2019-2024 (%)
  • 37: ROW - Market size and forecast 2019-2024 ($ million)
  • 38: ROW - Year-over-year growth 2019-2024 (%)
  • 39: Key leading countries
  • 40: Market opportunity by geography ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: Abbott Laboratories - Overview
  • 48: Abbott Laboratories - Business segments
  • 49: Abbott Laboratories - Key offerings
  • 50: Abbott Laboratories - Key customers
  • 51: Abbott Laboratories - Segment focus
  • 52: BioStable Science & Engineering Inc. - Overview
  • 53: BioStable Science & Engineering Inc. - Product and service
  • 54: BioStable Science & Engineering Inc. - Key offerings
  • 55: BioStable Science & Engineering Inc. - Key customers
  • 56: BioStable Science & Engineering Inc. - Segment focus
  • 57: Boston Scientific Corp. - Overview
  • 58: Boston Scientific Corp. - Business segments
  • 59: Boston Scientific Corp. - Key offerings
  • 60: Boston Scientific Corp. - Key customers
  • 61: Boston Scientific Corp. - Segment focus
  • 62: CORONEO Inc. - Overview
  • 63: CORONEO Inc. - Product and service
  • 64: CORONEO Inc. - Key offerings
  • 65: CORONEO Inc. - Key customers
  • 66: CORONEO Inc. - Segment focus
  • 67: Edwards Lifesciences Corp. - Overview
  • 68: Edwards Lifesciences Corp. - Product and service
  • 69: Edwards Lifesciences Corp. - Key offerings
  • 70: Edwards Lifesciences Corp. - Key customers
  • 71: Edwards Lifesciences Corp. - Segment focus
  • 72: Genesee BioMedical Inc. - Overview
  • 73: Genesee BioMedical Inc. - Product and service
  • 74: Genesee BioMedical Inc. - Key offerings
  • 75: Genesee BioMedical Inc. - Key customers
  • 76: Genesee BioMedical Inc. - Segment focus
  • 77: Kephalios - Overview
  • 78: Kephalios - Product and service
  • 79: Kephalios - Key offerings
  • 80: Kephalios - Key customers
  • 81: Kephalios - Segment focus
  • 82: LivaNova Plc - Overview
  • 83: LivaNova Plc - Business segments
  • 84: LivaNova Plc - Key offerings
  • 85: LivaNova Plc - Key customers
  • 86: LivaNova Plc - Segment focus
  • 87: Medtronic Plc - Overview
  • 88: Medtronic Plc - Business segments
  • 89: Medtronic Plc - Key offerings
  • 90: Medtronic Plc - Key customers
  • 91: Medtronic Plc - Segment focus
  • 92: Valcare Medical - Overview
  • 93: Valcare Medical - Product and service
  • 94: Valcare Medical - Key offerings
  • 95: Valcare Medical - Key customers
  • 96: Valcare Medical - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations
Back to Top